Nanographene oxide-based radioimmunoconstructs for in vivo targeting and SPECT imaging of HER2-positive tumors
Authors:
- Bart CornelissenBCBart Cornelissen
- Sarah AbleSASarah Able
- Veerle KersemansVKVeerle Kersemans
- Philip A. WaghornPWPhilip A. Waghorn
- Sverre MyhraSMSverre Myhra
- Kerstin JurkshatKJKerstin Jurkshat
- Alison CrossleyACAlison Crossley
- Katherine A. VallisKatherine A. Vallis
- 1 January 2013
- journal article
- research article
- Published by Elsevier in Biomaterials
- Vol. 34 (4) , 1146-1154
Abstract
No abstract availableKeywords
Funding Information
- Oxford Cancer Imaging Centre
- Cancer Research UK
- National Institute for Health Research
- Engineering and Physical Sciences Research Council
- Medical Research Council
This publication has 36 references indexed in Scilit:
- In vivo targeting and positron emission tomography imaging of tumor vasculature with 66Ga-labeled nano-grapheneBiomaterials, 2012
- Multimodal Imaging Guided Photothermal Therapy using Functionalized Graphene Nanosheets Anchored with Magnetic NanoparticlesAdvanced Materials, 2012
- In Vivo Targeting and Imaging of Tumor Vasculature with Radiolabeled, Antibody-Conjugated NanographeneACS Nano, 2012
- Graphene Oxide NanocolloidsJournal of the American Chemical Society, 2010
- Molecular imaging of HER2-positive breast cancer: a step toward an individualized ‘image and treat’ strategyCurrent Opinion in Oncology, 2010
- Functional Graphene Oxide as a Nanocarrier for Controlled Loading and Targeted Delivery of Mixed Anticancer DrugsSmall, 2010
- The chemistry of graphene oxideChemical Society Reviews, 2009
- Nano-graphene oxide for cellular imaging and drug deliveryNano Research, 2008
- Studies on the catabolism and distribution of fibrinogen in rats. Application of the iodogen® labelling techniqueBiochemical and Biophysical Research Communications, 1980
- Preparation of Graphitic OxideJournal of the American Chemical Society, 1958